pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Adapalene
drug
save

adapalene

Marketedupdated 5mo ago
by PL Developments Copiague LLC
Approved
community read0 votes

🐶 often sniffed alongside

top 1
  • tagApproval6 co-mentions · 3 sources

all catalysts(0)

nothing on the calendar yet

Trials studying adapalene

  • —Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Triple Combination Gel in Canadian Patients With Acne Vulgariscompletedn=200
  • N/ARadiofrequency Treatment Versus Topical Therapy for Facial Acne Vulgarisrecruitingn=60
  • phase4Study to Assess Safety, Pharmacokinetics, and Treatment Effect of Cabtreonot yet recruitingn=100
  • EP1Experience With Topical Acne Treatmentactive not recruitingn=72
  • phase4A Study Assessing the Efficacy of Combined Use of Clascoterone 1% Cream and Adapalene 0.3% for the Treatment of Acnecompletedn=20
  • phase1A Study Comparing Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Topical Gel 0.15%;3.1%;1.2% (Taro Pharmaceuticals U.S.A., Inc.) and CABTREO Topical Gel for the Treatment of Acne Vulgaris.completedn=382
  • phase3Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgariscompletedn=1,668
  • phase3Long-term Study of Efficacy/Safety of Adapalene/Benzoyl Peroxide Topical Gel in Acne Vulgaris Subjectscompletedn=452

Patent cliff

source: FDA Orange Book
first barrier falls
Jul 18, 2027
287 days

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (6)

  • May 31, 2028formulationUS 79984671.7y
  • Jul 18, 2027formulationUS 8071644287d
  • Jul 18, 2027method-of-use (U-1078)US 8080537287d
  • Jul 18, 2027method-of-use (U-1078)US 8129362287d
  • Sep 15, 2026formulationUS 8435502
  • Sep 15, 2026formulationUS 8709392

News(0)

no news has mentioned this drug yet

brand
Adapalene
generic
adapalene
indication
Acne Vulgaris
phase
marketed
Data sources
ClinicalTrials.gov
last refreshed 1h ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?